0001232524-18-000196.txt : 20181119
0001232524-18-000196.hdr.sgml : 20181119
20181119173256
ACCESSION NUMBER: 0001232524-18-000196
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181115
FILED AS OF DATE: 20181119
DATE AS OF CHANGE: 20181119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mulligan Seamus
CENTRAL INDEX KEY: 0001536639
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33500
FILM NUMBER: 181193593
MAIL ADDRESS:
STREET 1: 45 FITZWILLIAM SQUARE
CITY: DUBLIN
STATE: L2
ZIP: 2
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jazz Pharmaceuticals plc
CENTRAL INDEX KEY: 0001232524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981032470
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: FIFTH FLOOR, WATERLOO EXCHANGE
STREET 2: WATERLOO ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 353-1-634-7800
MAIL ADDRESS:
STREET 1: FIFTH FLOOR, WATERLOO EXCHANGE
STREET 2: WATERLOO ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: JAZZ PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030513
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2018-11-15
0
0001232524
Jazz Pharmaceuticals plc
JAZZ
0001536639
Mulligan Seamus
5TH FL, WATERLOO EXCHANGE
WATERLOO RD
DUBLIN 4
L2
IRELAND
1
0
0
0
Ordinary Shares
2018-11-15
4
P
0
300
141.8633
A
1051168
D
Ordinary Shares
2018-11-15
4
P
0
1200
143.2242
A
1052368
D
Ordinary Shares
2018-11-15
4
P
0
26363
144.2431
A
1078731
D
Ordinary Shares
2018-11-15
4
P
0
22137
145.0464
A
1100868
D
Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $141.52 to $142.04. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.
Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $142.67 to $143.60. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.
Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $143.69 to $144.67. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.
Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $144.69 to $145.56. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.
By: /s/Peter A Christou, as attorney in fact For: Seamus Mulligan
2018-11-19